Top Stories
-
New combination chemotherapies have improved survival for patients with pancreatic cancer, and oncologist Gulam Manji sees early signs that new treatments in trials may be even better.
-
Columbia researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.
Topic
-
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
Topic
-
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
Topic
Latest News
- December 22, 2017
Cancer researchers at Columbia have discovered three genes that undermine the DNA repair process and promote tumor formation in cells with BRCA mutations.
Topic
- December 20, 2017
Using electron microscopy, CUMC biologists have captured the first detailed images of a calcium membrane pore in action, revealing a potential target for treating cancer.
Topic
- December 14, 2017
An individual’s own genes play a role in the response to immunotherapy drugs, researchers in the Herbert Irving Comprehensive Cancer Center have found.
Topic
- December 8, 2017
A CUMC-led study finds that acupuncture can reduce the joint pain caused by aromatase inhibitors, a drug taken by two-thirds of all breast cancer patients.
Topic
- November 16, 2017
Columbia University and NYP announced today that Florence Irving and her late husband, Herbert Irving, have given $700 million to the two institutions to dramatically advance research and clinical programs for the treatment of cancer.
Topic
- November 16, 2017
Discoveries made by researchers at HICCC have fundamentally altered our understanding of cancer.
- October 11, 2017
Columbia researchers have identified cells that give rise to Barrett’s esophagus, a precursor to esophageal cancer, the fastest-growing cancer in the United States.
Topic
- October 9, 2017
Riders, sponsors, volunteers, and friends joined forces for Velocity, Columbia's Ride to End Cancer, in support of the Herbert Irving Comprehensive Cancer Center.
Topic
- September 7, 2017
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Topic
- August 30, 2017
Immunotherapy expert Pawel Muranski speaks about the new CAR-T therapy for leukemia and his work to bring T cell therapies to patients with a wide range of cancers.
Topic
